Ignore Nifty, Focus on Fundamentals: 6 Stocks Across Sectors with Up to 42% Upside Potential
In times of market correction, it’s easy to lose focus and react to the noise. But successful investing requires staying rational and looking beyond short-term market swings. History has shown that panicking during corrections often results in missed opportunities. Instead of focusing on where the Nifty or Sensex stand, it’s time to focus on business fundamentals that drive long-term value.
Amid the current market volatility, here’s a list of six stocks from different sectors, each with a strong “Buy” or “Hold” rating and an upside potential of up to 42%. These stocks represent sectors where demand is steady, relatively unaffected by market cycles.
Why Staying Focused on Fundamentals Matters
If you own shares in a healthcare or utility company, does the Nifty’s position really impact its business or demand? The answer is usually no. However, if you own a brokerage or exchange stock, market movements might have some effect, but this would likely be temporary.
Instead of reacting to short-term price drops, look at each company’s business model, competitive position, and long-term potential. This is the approach that can help you stay on course through volatile markets.
6 Stocks with Strong Business Fundamentals and Upside Potential
- Aurobindo Pharma Limited
- Sector: Pharmaceuticals
- Business: Aurobindo Pharma is a global pharmaceutical company offering a wide range of generics, branded drugs, and active pharmaceutical ingredients. The company operates across therapeutic areas such as CNS, cardiovascular, anti-diabetic, and more.
- Why It’s a Buy: With an expanding product pipeline, particularly in specialty pharmaceuticals and oncology, Aurobindo is well-positioned for growth. Its strong global footprint supports a diversified revenue stream.
- Shriram Finance Limited
- Sector: Financial Services (NBFC)
- Business: Shriram Finance provides credit solutions across sectors, offering loans for commercial vehicles, two-wheelers, housing, and more. It serves a wide range of customers, including those in underbanked and unbanked segments.
- Why It’s a Buy: With its innovative digital offerings and focus on financial inclusion, Shriram Finance stands out as a key player in the NBFC space. Its diversified loan portfolio and market reach position it for steady growth.
- LIC Housing Finance Limited
- Sector: Housing Finance
- Business: LIC Housing Finance provides long-term finance for home purchases, construction, and renovation. It also offers loans against property and loans for small businesses.
- Why It’s a Buy: Supported by favorable demographics and rising demand for affordable housing, LIC Housing Finance benefits from strong fundamentals. Government initiatives aimed at increasing homeownership offer further tailwinds.
- EIH Limited
- Sector: Hospitality and Tourism
- Business: EIH, under the Oberoi and Trident brands, owns and operates luxury hotels, as well as offering flight catering and other hospitality services. With properties across India, Egypt, and other regions, EIH serves a premium market segment.
- Why It’s a Buy: With a strong brand reputation and diversified hospitality offerings, EIH is poised for growth as travel and tourism rebound post-pandemic. Its expansion in international luxury markets enhances its growth potential.
- Narayana Hrudayalaya Limited
- Sector: Healthcare
- Business: Narayana Hrudayalaya operates a network of hospitals and healthcare facilities, providing a wide range of medical services across specialties such as cardiology, oncology, and orthopedics.
- Why It’s a Buy: With India’s growing healthcare demand and a commitment to affordable care, Narayana Hrudayalaya’s business model offers resilience and growth. Its presence in both India and overseas markets supports a diversified revenue base.
- Dr. Lal PathLabs Limited
- Sector: Diagnostics and Healthcare Services
- Business: Dr. Lal PathLabs provides diagnostic services, offering an extensive range of tests across various healthcare conditions. With operations in India, Nepal, and Bangladesh, the company is one of India’s leading diagnostic chains.
- Why It’s a Buy: The growing awareness of preventive healthcare and increased demand for diagnostics support Dr. Lal PathLabs’ growth prospects. Its broad network of labs and brand recognition give it a competitive edge.
Key Takeaways for Long-Term Investors
- Stay Focused on Business Fundamentals: Avoid making decisions based on short-term price movements. Evaluate each company based on its business strength and future prospects.
- Invest Incrementally: Consider deploying funds in phases, especially if you’re focusing on large caps or well-established mid-caps. Market corrections are common, and this approach can help balance volatility.
- Keep a Long-Term Horizon: Be prepared to let your investments underperform in the short term if necessary. Stocks with solid fundamentals are more likely to weather economic cycles and deliver growth over time.
Final Thoughts
In a market correction, it’s easy to get distracted by the noise, but investors who stick to the basics of business and focus on long-term fundamentals are better positioned to succeed. The six stocks listed here offer potential returns and represent sectors with strong demand drivers, making them suitable candidates for long-term investment portfolios.
Disclaimer: This article is for informational purposes only and should not be considered financial advice. Please consult a certified financial advisor before making investment decisions.